Allenspach EJ, Maillard I, Aster C, Warren S: Notch Signaling in Cancer. Cancer Biol Ther 2002, 5: 466–476.
Article
Google Scholar
Allison RR, Schulsinger A, Vongtama V: Radiation and chemotherapy improve outcome in oligodendroglioma. Int J Radiat Oncol Biol Phys 1997, 37: 399–403. 10.1016/S0360-3016(96)00452-X
Article
CAS
Google Scholar
Alterovitz G, Xiang M, Liu J, Chang MF: System-wide peripheral biomarker discovery using information theory. P.S.biocomuting 2008, 13: 231–242.
Google Scholar
Anderson NL, Anderson NG: Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998, 19: 1853–1861. 10.1002/elps.1150191103
Article
CAS
Google Scholar
Anthony B, Khe HX, Antoine FC, Delattre JV: Primary brain tumours in adults. Lancet 2003, 361: 323–31. 10.1016/S0140-6736(03)12328-8
Article
Google Scholar
Blackstock WP, Weir MP: Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 1999, 17: 121–127. 10.1016/S0167-7799(98)01245-1
Article
CAS
Google Scholar
Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988, 23: 360–364. 10.1002/ana.410230408
Article
CAS
Google Scholar
Cairncross JG, Macdonald DR, Ramsay DA: Aggressive oligodendroglioma: A chemosensitive tumor. Neurosurgery 1992, 31: 78–82. 10.1227/00006123-199207000-00011
Article
CAS
Google Scholar
Cairncross JG, Ueki K, Zlatescu MC: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90: 1473–1479. 10.1093/jnci/90.19.1473
Article
CAS
Google Scholar
Cao R, Liang S: Liver plasma membranes: an effective method to analyze membrane proteome. Methods Mol Biol 2012, 909: 113–123.
CAS
Google Scholar
Cao XM, Meng HS, Hong F, Ying QS: Fibroblast Growth Factor Receptor 4 Regulates Proliferation and Antiapoptosis During Gastric Cancer Progression. Cancer 2011, 1: 5340–5313.
Google Scholar
Glass J, Hochberg FH, Gruber ML: The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 1992, 76: 741–745. 10.3171/jns.1992.76.5.0741
Article
CAS
Google Scholar
Gregory J, Keisuke U, Magdelena CZ, David KL: Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas. J Natl Cancer Inst 1998, 90: 1473–1479. 10.1093/jnci/90.19.1473
Article
Google Scholar
James P: Protein identification in the post-genome era: the rapid rise of proteomics. Q Rev Biophys 1997, 30: 279–331. 10.1017/S0033583597003399
Article
CAS
Google Scholar
Kim YH, Cho K, Yun SH, Kim JY, Kwon KH, Yoo JS, Kim SI: Analysis of aromatic catabolic pathways in Pseudomonas putida KT 2440 using a combined proteomic approach: 2-DE/MS and cleavable isotope-coded affinity tag analysis. Proteomics 2006, 6: 1301–1318. 10.1002/pmic.200500329
Article
CAS
Google Scholar
Kim G, Park EC, Chung HR, Jeon SS, Kim SI, Jang HS, Kim GH, Choi BO: MicroRNA expression profiling in recurrent anaplastic oligodendroglioma treated with postoperative radiotherapy. JAST 2011, 2: 97–104. 10.5355/JAST.2011.97
Article
Google Scholar
Kleinberg L, Wallner K, Malkin MG: Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 1993, 26: 129–133. 10.1016/0360-3016(93)90183-V
Article
CAS
Google Scholar
Kyritsis AP, Yung WK, Bruner J: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993, 32: 365–370. 10.1227/00006123-199303000-00005
Article
CAS
Google Scholar
Lee AS: Mammalian stress response: induction of the glucose-regulated protein family. Curr Opin Cell Biol 1992, 4: 267–273. 10.1016/0955-0674(92)90042-B
Article
CAS
Google Scholar
Lee AS: The glucose-regulated proteins: stress induction and clinical application. Trends Biochem Sci 2001, 26: 504–511. 10.1016/S0968-0004(01)01908-9
Article
CAS
Google Scholar
Mason WP, Krol GS, DeAngelis LM: Low-grade oligodendroglioma responds to chemotherapy. Neurology 1996, 46: 203–207. 10.1212/WNL.46.1.203
Article
CAS
Google Scholar
Normanno N, Bianco C, De Luca A, Salomon DS: The role of EGF related peptides in tumor growth. Front Biosci 2001, 6: d685-d707. 10.2741/Normano
Article
CAS
Google Scholar
Paul P: Wnt signaling and cancer. Genes Dev 2000, 14: 1837–1851.
Google Scholar
Williams J, Lucas PC, Griffith KA: Expression of BclxL in ovarian carcinoma is associated with chemoresistance and recurrent disease. Gynecol Oncol 2005, 96: 287–295. 10.1016/j.ygyno.2004.10.026
Article
CAS
Google Scholar
Ymazaki D, Kurisu S, Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005, 96: 379–386. 10.1111/j.1349-7006.2005.00062.x
Article
Google Scholar
Zang XP, Bullen EC, Manjeshwar S, Jupe ER, Howard EW, Pneto JT: Enhanced motility of KGF-transfected breast cancer cells. Anticancer reseatch 2006, 26: 961–966.
CAS
Google Scholar